General Information of Drug (ID: DMQI1EW)

Drug Name
ARO-RAGE
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Phase 1 [1]
Drug Type
RNA interference
Cross-matching ID
TTD ID
D8JN6C

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Advanced glycosylation end product-specific receptor messenger RNA (AGER mRNA) TTDUDE4 RAGE_HUMAN Antagonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05533294) A Phase 1 Study Evaluating the Effects of ARO-RAGE Injection for Subcutaneous Administration in Healthy Subjects. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Arrowhead Pharmaceuticals